Delivery Order SPE2DB20D1100-SPE2DB24FB6Z5
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The award, valued at $18,336.06, is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product, to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major...
- This federal contract award is a delivery order valued at $10,205.77 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, with a period of performance through March 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $9,313.41 and a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $23,490.57 firm-fixed-price contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has a completion date of June 26, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $9,334.98 firm fixed-price delivery order contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a period of performance through June 25, 2025 and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $46,898.76 Firm Fixed Price Delivery Order contract is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide RINVOQ ER 15 MG TABLET medical supplies. The firm-fixed-price delivery order has a ceiling value of $34,338.00 and a completion date of November 1, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,313.23 delivery order contract is for the supply of RINVOQ ER 45 MG TABLET, a pharmaceutical product. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division, issued by the Defense Logistics Agency (DLA), provides for the delivery of RINVOQ ER 30 MG TABLET medication. The single-award Indefinite Delivery Contract (IDC) has a ceiling value of $19,996.33 and runs through June 2024. AmerisourceBergen holds a larger DLA Troop Support Medical IDC valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564360779 RINVOQ ER 30 MG TABLET UU 30S. The $3,407.57 Firm Fixed Price contract was awarded on April 22, 2024 by the Defense Logistics Agency (DLA), with an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB6Z5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies, leverages its extensive supply chain network to efficiently manage the logistics of supplying critical medical products to government agencies, including the DoD and Department of Veterans Affairs (VA) healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 5/8/24 |